Types of Cancer We Treat

Prostate Cancer

Our nationally and internationally known specialists offer the most up-to-date, research-backed prostate cancer treatments, including targeted ablation using cryo-ablation and high-intensity focused ultrasound, or HIFU. Our comprehensive services include precision screening, diagnosis, post-treatment rehabilitation, and integrative therapies, as well as second opinion consultations to help you better understand your testing and treatment options.

Perlmutter Cancer Center doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and those who can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can actively partner in creating a personalized treatment plan that’s right for you.

Find a Doctor & Schedule
Diagnosis
Active Surveillance
Surgery
Radiation Therapy
Minimally Invasive Ablation Treatment
Hormone Therapies & Other Systemic Therapies

Related News

High-Tech Radiation Treatment Shortens Recovery Time
Read Story
New Study Tests MRI-Targeted Prostate Biopsy Strategy
Read Story
Biomarker Tests Yield Conflicting Advice on Prostate Biopsy
Read Story
Study Examines Early Biopsy After Partial-Gland Cryoablation
Read Story
Immunotherapy Does Not Increase Risk for Prostate Cancer
Read Story
Medical Oncologist Advances Treatments for Prostate Cancer
Read Story
Questions to Consider When Consulting Online Medical Videos
Read Story
Urologic Cancer Expert Brings Latest Science to Brooklyn
Read Story
Treating Prostate Cancer with No Surgery & Fewer Risks
Read Story
What to Ask Your Doctor About Prostate Cancer
Read Story
Navigating a Prostate Cancer Diagnosis
Read Story
Low-Risk Prostate Cancer Strategies for Veterans
Read Story

Clinical Trials and Research Studies

Phase 3

Phase 3 Randomized Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)

Learn More

Phase 5

A Phase 1b/2 Open-Label Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer

Learn More

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More

Phase 5

A Parallel-Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

Learn More
View All Related Clinical Trials (7)